Iridian Asset Management’s Bausch Health BHC Stock Holding History

Iridian Asset Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,324,602	Closed	-$440M	–	65
2015 Q4	$440M	Buy	4,324,602 +1,607,834	+59%	+$181M	3.61%	7
2015 Q3	$485M	Sell	2,716,768 -238,803	-8%	-$55.7M	4.1%	5
2015 Q2	$657M	Sell	2,955,571 -87,966	-3%	-$19.5M	5.17%	1
2015 Q1	$605M	Sell	3,043,537 -858,795	-22%	-$152M	5.09%	2
2014 Q4	$558M	Buy	3,902,332 +196,381	+5%	+$26.4M	5.19%	1
2014 Q3	$486M	Sell	3,705,951 -31,910	-0.9%	-$3.8M	5.01%	1
2014 Q2	$471M	Buy	3,737,861 +668,990	+22%	+$85.3M	4.83%	1
2014 Q1	$405M	Sell	3,068,871 -416,529	-12%	-$57M	4.62%	1
2013 Q4	$409M	Buy	3,485,400 +90,692	+3%	+$9.94M	4.85%	1
2013 Q3	$354M	Buy	3,394,708 +31,140	+0.9%	+$3.03M	4.73%	2
2013 Q2	$290M	Buy	+3,363,568	New	+$265M	3.65%	6

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Iridian Asset Management's BHC Position: Q1 2016 in Review

Iridian Asset Management sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 4,324,602 shares — an estimated $440M sold.

Iridian Asset Management first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $657M in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Iridian Asset Management reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Iridian Asset Management sold 4,324,602 Bausch Health shares in Q1 2016, an estimated $440M.
Iridian Asset Management first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
Iridian Asset Management's Bausch Health position peaked at $657M in Q2 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Iridian Asset Management's 13F filing for Q1 2016, filed 10 May 2016.